Evidence map›Paper›PMID 41827843›Full record

ArticleCells2026

Preventive Aerobic Training Protects Against Doxorubicin-Induced Cardiotoxicity by Preserving Redox Status and Attenuating Cardiac Stress-Related Signaling.

Paola Victória da Costa Ghignatti, Rafael Aguiar Marschner, Rafael Teixeira Ribeiro, Vitor Gayger-Dias, Vanessa-Fernanda Da Silva, Luciele Varaschini Teixeira, Simone Wajner, Maximiliano Isoppo Schaun, Carlos-Alberto Gonçalves, Patrícia Sesterheim

Abstract read
In one paragraph

Article in Cells, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Paola Victória da Costa GhignattiInstitute of Cardiology of Rio Grande do Sul, University Foundation of Cardiology (IC/FUC), Porto Alegre 90040-371, RS, Brazil.ORCID 0000-0002-1166-0982
Rafael Aguiar MarschnerBiochemistry Department, Basic Sciences Institute of Health, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre 91501-970, RS, Brazil.ORCID 0000-0002-8588-7362
Rafael Teixeira RibeiroBiochemistry Department, Basic Sciences Institute of Health, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre 91501-970, RS, Brazil.ORCID 0000-0001-5814-6369
Vitor Gayger-DiasBiochemistry Department, Basic Sciences Institute of Health, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre 91501-970, RS, Brazil.ORCID 0000-0002-8067-9505
Vanessa-Fernanda Da SilvaBiochemistry Department, Basic Sciences Institute of Health, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre 91501-970, RS, Brazil.ORCID 0009-0001-5917-4887
Luciele Varaschini TeixeiraInstitute of Cardiology of Rio Grande do Sul, University Foundation of Cardiology (IC/FUC), Porto Alegre 90040-371, RS, Brazil.
Simone WajnerEndocrine Division, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre 90035-003, RS, Brazil.ORCID 0000-0002-8942-244X
Maximiliano Isoppo SchaunInstitute of Cardiology of Rio Grande do Sul, University Foundation of Cardiology (IC/FUC), Porto Alegre 90040-371, RS, Brazil.
Carlos-Alberto GonçalvesBiochemistry Department, Basic Sciences Institute of Health, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre 91501-970, RS, Brazil.ORCID 0000-0001-8430-5650
Patrícia SesterheimInstitute of Cardiology of Rio Grande do Sul, University Foundation of Cardiology (IC/FUC), Porto Alegre 90040-371, RS, Brazil.

Funding

Coordenação de Aperfeicoamento de Pessoal de Nível Superior 001
6 · The paper itself

Abstract

Doxorubicin (DOX) is a highly effective chemotherapeutic agent whose clinical use is limited by dose-dependent cardiotoxicity associated with oxidative stress, inflammation, and cellular stress responses. Here, we investigated whether preventive aerobic training could protect against DOX-induced cardiac injury in Wistar rats. Animals were assigned to sedentary control (C), sedentary DOX (D), trained control (CT), and trained DOX (DT) groups. The moderate-intensity (~50-80% maximal exercise test) treadmill protocol (40 min/day, 4 days/week for 4 weeks) was performed before intraperitoneal administration of DOX (4 mg/kg, weekly for 4 weeks) or saline. Preventive training markedly improved exercise capacity (

Indexed as

CardiotoxicityDoxorubicinPhysical Conditioning, AnimalSignal TransductionAnimalsMaleMyocardiumOxidation-ReductionOxidative StressRatsRats, WistarDoxorubicinaerobic trainingcardiotoxicitydoxorubicinheartoxidative stress

Identifiers

PMID41827843
PMCPMC12985090

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.